Mental Disorders and Learning Disabilities in Children and Adolescents: Attention-Deficit/Hyperactivity Disorder

Area of Science:

• Pediatric Medicine
• Neurobehavioral Disorders
• Family Medicine

Background:

• Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurobehavioral condition affecting over 9% of US children and adolescents.
• ADHD is frequently encountered in family medicine settings, necessitating effective diagnostic and management strategies.

Purpose of the Study:

• To outline a comprehensive approach to evaluating and diagnosing ADHD in pediatric populations.
• To review evidence-based management strategies for ADHD, considering age-specific recommendations.
• To emphasize the importance of ongoing monitoring for individuals with ADHD.

Main Methods:

• Comprehensive evaluation involves gathering information across time and settings.
• Assessment includes screening for common comorbidities (learning disabilities, mood/anxiety disorders, sensory impairments) and a physical examination.
• Diagnosis relies on established criteria for inattention and/or hyperactive/impulsive symptoms beginning before age 12.

Main Results:

• Behavioral treatment is the first-line therapy for preschoolers and benefits school-aged children.
• Pharmacotherapy, particularly stimulant drugs, effectively addresses core ADHD symptoms in most patients.
• Adverse effects of stimulant medications are more common in preschoolers, with alternative options available.

Conclusions:

• Effective ADHD management requires a multi-faceted approach tailored to patient age.
• Psychosocial-behavioral interventions and pharmacotherapy are key components of evidence-based care.
• Regular monitoring is essential for optimizing treatment and managing potential adverse effects throughout the lifespan.